Sandra B Gabelli

Molecular mechanisms of deregulation in cancer and cardiovascular disease We are interested on studying molecular abnormalities that underlie diseases to design targeted molecular therapies. Specifically, alterations in the regulation and protein:protein interaction due to mutations are implicated from cancer to cardiovascular disease. Understanding the structural and mechanistic details of each signaling event and the protein-protein interactions involved is our key to design the next gene